ABSTRACT -We a case of chronic Aspergillus sp. meningitis in a healthy 43-year-old woman successfully treated with fluconazole given orally (300 ms/day). The diagnosis was made by detection of anti-aspergillus antibodies and positive culture to Aspergillus sp. in the cerebrospinal fluid.
The laboratory data showed a hematocrit value of 41% and a white blood cell (WBC) count of 8,300/ mm3, with normal differential count. The chest X-ray was normal. A spinal tap showed normal opening pressure. The cerebrospinal fluid (CSF) was clear; with 21 cells/mm3 (100% lymphocytes) protein 91 mg/dL; glucose 34 mg/dL. VDRL was not reactive and cultures were negative for common fungi or bacteria. In the following CSF samples, leukocytes and protein increased, as shown in Table 1 .
The patient stayed 12 days at the hospital, and was submitted to several radiological and laboratory tests. Computerized axial tomography and resonance magnetic imaging were normal. The enzyme-linked immunosorbent assay (ELISA) for HIV 1 and 2 was repeatedly negative. Other two samples of CSF were collected and cultures to bacteria and fungi were negative, slide latex agglutination (SLA) tests to cryptococcal antigen, Haemophilus influenza, Neisseria meningitidis, Streptococcus pneumoniae were negative.
The patient was followed on consultations and five CSF examinations were done during a follow up period of a month, when the diagnosis was finally established. In the first CSF sample, a polymerase chain reaction (PCR) to Mycobacterium tuberculosis was negative. In the next CSF sample, culture to fungi was positive to Aspergillus sp and the immunodiffusion test showed presence of antibodies against Aspergillus sp. Other immunological tests to Histoplasma, Cysticercus and Sporothrix were negative.
At the time of diagnosis of Aspergillus meningitis, treatment with amphotericin was indicated, but the patient refused to be readmitted. As a therapeutic alternative, fluconazole (300mg/day) PO was started and kept for 4 months. The medication was well tolerated, without side-effects. During treatment, headache subsided and the CSF abnormalities improved, the culture to fungi was negative and immunodiffusion test was negative.
After two years of treatment, the patient is asymptomatic, without any sign/symptom of systemic disease or recurrence of meningitis.
DISCUSSION
Aspergillus is second only to Candida in the frequency of opportunistic mycosis among immunocompromised hosts. This condition is more frequent in patients with leukemia, lymphoreticular neoplasms, those on long-term use of steroid, large spectrum-antibiotics, cancer chemotherapy, those on immunosuppressant drugs following renal or cardiac transplantation. More recently CNS Aspergillus infection is a well recognized complication in patients with acquired immunodeficiency syndrome. In all these patients, cellular immunity is greatly impaired [9] [10] [11] [12] [13] . The infections can be divided in two types: localized or disseminated. The latter usually occurs in compromised host, and CNS involvement is present in 40-60% of cases. Invasion of the CNS occurs either by direct extension from an area adjacent to the brain, or by hematogenous route. In some patients, the mechanism of CNS penetration is unclear. The direct extension to the brain may occur from adjacent structure, i.e., ear, nose, paranasal sinuses; orbit; and sphenoid sinus or following head trauma. Iatrogenic introduction of Aspergillus into the CNS has been described following spinal tap, craniotomies, and after implantation of radioactive ytrium for pituitary ablation 4, 14 .
The hematogenous route is usually associated with lung and gastrointestinal infections in immunosuppressed host, but it can also result from direct blood-stream inoculation of fungus during illicit drug use or following open heart surgery 15 .
CNS aspergillosis can present as subcortical hemorrhagic infarcts in cerebral hemispheres; abscesses; granulomas; mycotic aneurysms; and meningitis. The subcortical infarctions, hemorrhage and mycotic aneurysms reflect the vascular invasion of small and large cerebral vessels, leading to thrombosis or destruction of the internal elastic lamina of cerebral arteries 4, 16 . Brain abscesses present as multiple lesions with hyphae, a focal mixed polymorphonuclear and mononuclear reaction, and usually occurs in the frontal and temporal lobes. Granuloma formation is seen in those patients who have had aspergillosis for a prolonged period of time, particularly if the lesions are limited to the CNS and/or adjacent paranasal sinuses or orbit 17, 18 . Spinal cord compression has also been recorded. Meningitis as the predominant clinicopathological process has been reported in only a few cases 9, 12, 15, 17 . In autopsy series the meninges were focally involved in areas adjacent to local infection in cerebral hemispheres 19 .
There are not pathognomonic features in CSF examination in patients with CNS aspergillosis. CSF is usually clear; with normal or increased opening pressure; the glucose level may be normal or depressed; the protein is elevated (above 100mg/dL); pleocytosis is usually less than 600 cells/mm3 with a variable distribution of polymorphonuclear and mononuclear cells. Positive CSF cultures to Aspergillus are rare 5, 7, 20 . Aspergillus rarely invades the meninges, and the lack of diffuse meningeal involvement might be the reason of relative paucity of CSF findings 19 .
Diagnosis of CNS aspergillosis is difficult. Positive CSF culture gives a straight diagnosis, however they are usually negative. Therefore, other tests may be helpful in the diagnosis of this lifethreatening pathology. Morrow et al. 15 described the presence of antibodies by double immunodiffusion in 2 out of 3 patients, who had negative cultures but antibodies were shown by double immunodiffusion. These patients were cured after treatment with antifungal drugs. Western blot analysis can be used for detection of Aspergillus antigen in CSF. The presence of prominent 110KD band can be a prognostic marker in fatal aspergillosis 21 . Our case showed both positive cultures and immunodiffusion test, but only after many CSF samplings.
The treatment of choice for CNS meningitis is amphotericin B, or amphotericin plus flucytosine 1, 9, 22 . However, successful treatment is not the rule, perhaps reflecting a late diagnosis or may be related to poor response to antifungal drug 1, 9, 22, 23 . Other therapeutic alternatives include the use of parenteral or oral imidazole compounds, e.g. fluconazole and itraconazole 1, 9, 23, 24 . Mikolich et al. 25 reported the use of itraconazole with success in an immunocompetent patient with Aspergillus meningitis. More recently, Renard et al. 3 reported another case of neuroaspergillosis associated with neurotuberculosis in an immunocompetent woman treated with antituberculous agents and itraconazole with good outcome. In a minority of patients with clinical tuberculosis a risk factor can be identified. However, most patients develop tuberculosis, and possibly some fungal infections, e.g. aspergillosis, as a result of complex interaction of environmental and genectic factors, like NRAMP 1 (natural-resistance-associated macrophage protein 1) polymorphism in tuberculosis 27 .
Fluconazole is a synthetic broad-spectrum triazole compound with good properties for treatment of CNS infections. It is more water-soluble than itraconazole or ketoconazole, and unlike these drugs, fluconazole is only approximately 11% protein-bound, what results a good penetration into CSF, with levels reaching 70-80% of simultaneous serum levels. Fluconazole is well absorbed after oral administration, has a long half-life in the CNS compartment, and the side effects are minimal comparing with amphotericin B 3, 28 . The treatment must be continued for at least 6 weeks or until evidence of active CNS infection has disappeared. This includes a normal CSF formula, negative CSF culture or antigen titers.
The findings in this case emphasize the importance in establishing an etiologic diagnosis in chronic meningitis, in order to choose the most appropriate therapy. This is the first report of neuroaspergillosis successfully treated with fluconazole. Fluconazole might be considered an alternative therapy to Aspergillus meningitis in selected patients.
